methyleugenol has been researched along with Colonic Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Esselen, M; Groh, IAM | 1 |
Esselen, M; Groh, IA; Gründken, M; Marko, D; Rudakovski, O; Schroeter, A | 1 |
2 other study(ies) available for methyleugenol and Colonic Neoplasms
Article | Year |
---|---|
Methyleugenol and selected oxidative metabolites affect DNA-Damage signalling pathways and induce apoptosis in human colon tumour HT29 cells.
Topics: Adenocarcinoma; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Colonic Neoplasms; DNA Damage; Eugenol; Gene Expression Regulation, Enzymologic; HT29 Cells; Humans; Molecular Structure; Oxidation-Reduction; Signal Transduction | 2017 |
Methyleugenol and oxidative metabolites induce DNA damage and interact with human topoisomerases.
Topics: Biomarkers, Tumor; Biotransformation; Carcinogens, Environmental; Carcinoma; Colonic Neoplasms; Comet Assay; DNA Damage; DNA Topoisomerases, Type I; Epoxy Compounds; Eugenol; Food Contamination; Histones; HT29 Cells; Humans; Micronucleus Tests; Mutagens; Neoplasm Proteins; Oxidation-Reduction; Phosphorylation; Protein Processing, Post-Translational; Recombinant Proteins; Spices; Topoisomerase I Inhibitors | 2016 |